Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
2
조회
0
다운로드
0
인용
0
참고문헌
초록
Background/Aims: Biliary stenting is the most effective decompressive method for treating malignant biliary obstructive jaundice. Although the main cause of stent occlusion is tumor growth, few studies have investigated whether stent patency is affected by the combination of cancer-treatment modalities. The aim of this study was to evaluate the effects of local radiotherapy on metal-stent patency in patients with malignant biliary obstruction. Methods: Patients who underwent self-expandable biliary metallic stenting for malignant biliary obstruction from 1999 to 2007 were included. Forty patients received chemotherapy and radiation therapy (radiation group, RG), and 31 patients received only chemotherapy (nonradiation group, NRG). Results: The cumulative median stent patency was significantly longer in the RG than in the NRG (17.7 months; 95% confidence interval [CI], 1.8to 33.6 months vs 8.7 months; 95% CI, 4.9 to 12.5 months;p=0.025). Stent occlusion caused by tumor growth or stent migration occurred in two (5%) and three (7.5%) cases in the RG and in six (19.3%) and two (6.5%) cases in the NRG,respectively. Conclusions: The patency of biliary metal stents in pancreatobiliary cancer patients who receive chemoradiation therapy is significantly longer than that in patients who do not receive radiotherapy, which suggests that local cancer control significantly affects stent patency.
Abstract
Background/Aims: Biliary stenting is the most effective decompressive method for treating malignant biliary obstructive jaundice. Although the main cause of stent occlusion is tumor growth, few studies have investigated whether stent patency is affected by the combination of cancer-treatment modalities. The aim of this study was to evaluate the effects of local radiotherapy on metal-stent patency in patients with malignant biliary obstruction. Methods: Patients who underwent self-expandable biliary metallic stenting for malignant biliary obstruction from 1999 to 2007 were included. Forty patients received chemotherapy and radiation therapy (radiation group, RG), and 31 patients received only chemotherapy (nonradiation group, NRG). Results: The cumulative median stent patency was significantly longer in the RG than in the NRG (17.7 months; 95% confidence interval [CI], 1.8to 33.6 months vs 8.7 months; 95% CI, 4.9 to 12.5 months;p=0.025). Stent occlusion caused by tumor growth or stent migration occurred in two (5%) and three (7.5%) cases in the RG and in six (19.3%) and two (6.5%) cases in the NRG,respectively. Conclusions: The patency of biliary metal stents in pancreatobiliary cancer patients who receive chemoradiation therapy is significantly longer than that in patients who do not receive radiotherapy, which suggests that local cancer control significantly affects stent patency.
참고문헌 (28)
- Moss AC, "Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results", Cancer Treat Rev, 33, pp.213~221 (2007)
- Conio M, "Endoscopic treatment of pancreatico-biliary malignancies", Crit Rev Oncol Hematol, 37, pp.127~135 (2001)
- Kahaleh M, "Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis", Endoscopy, 39, pp.319~324 (2007)
- Cipolletta L, "Italian Evidence-Based Gastroenterology & Hepatology Club. Endoscopic palliation of malignant obstructive jaundice: an evidence-based review", Dig Liver Dis, 39, pp.375~388 (2007)
- Brountzos EN, "A survival analysis of patients with malignant biliary strictures treated by percutaneous metallic stenting", Cardiovasc Intervent Radiol, 30, pp.66~73 (2007)
- Schmassmann A, "Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival", Am J Gastroenterol, 91, pp.654~659 (1996)
- Leung J, "The role of covered self-expandable metallic stents in malignant biliary strictures", Gastrointest Endosc, 63, pp.1001~1003 (2006)
- Eschelman DJ, "Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy", Radiology, 200, pp.717~724 (1996)
- Bowling TE, "A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma", Gut, 39, pp.852~855 (1996)
- Miura Y, "Adjuvant therapies using biliary stenting for malignant biliary obstruction", J Hepatobiliary Pancreat Surg, 8, pp.113~117 (2001)
- Qian XJ, "Treatment of malignant biliary obstruction by combined percutaneous transhepatic biliary drainage with local tumor treatment", World J Gastroenterol, 12, pp.331~335 (2006)
- "Weekly full-dose gemcitabine and single-dose cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer", BRITISH JOURNAL OF CANCER, 98, pp.881~887 (2008), NATURE PUBLISHING GROUP
- Valek V, "Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study", Eur J Radiol, 62, pp.175~179 (2007)
- Simmons DT, "A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma", Am J Gastroenterol, 101, pp.1792~1796 (2006)
- Yang KY, "A comparison of the Niti-D biliary uncovered stent and the uncovered Wallstent in malignant biliary obstruction", Gastrointest Endosc, 70, pp.45~51 (2009)
- Judah JR, "Endoscopic therapy of benign biliary strictures", World J Gastroenterol, 13, pp.3531~3539 (2007)
- Isayama H, "A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction", Gut, 53, pp.729~734 (2004)
- Yoon WJ, "A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction", Gastrointest Endosc, 63, pp.996~1000 (2006)
- Pinol V, "Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial", Radiology, 225, pp.27~34 (2002)
- Soderlund C, "Covered metal versus plastic stents for malignant common bile duct stenosis: a prospective, randomized, controlled trial", Gastrointest Endosc, 63, pp.986~995 (2006)
- Srikureja W, "Endoscopic palliation of pancreatic adenocarcinoma", Curr Opin Gastroenterol, 21, pp.601~605 (2005)
- Dua KS, "Impact of reducing duodenobiliary reflux on biliary stent patency: an in vitro evaluation and a prospective randomized clinical trial that used a biliary stent with an antireflux valve", Gastrointest Endosc, 65, pp.819~828 (2007)
- Takasawa O, "Endoscopic biliary drainage for patients with unresectable pancreatic cancer with obstructive jaundice who are to undergo gemcitabine chemotherapy", World J Gastroenterol, 12, pp.7299~7303 (2006)
- Wang J, "p53 status and its prognostic role in extrahepatic bile duct cancer: a meta-analysis of published studies", Dig Dis Sci, 56, pp.655~662 (2011)
- Singh P, "Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment", Pancreas, 40, pp.644~652 (2011)
- "SURGICAL OUTCOMES AND PROGNOSTIC FACTORS FOR AMPULLA OF VATER CANCER", Scand. J. Surg., 100(2), pp.92~98 (2011), 헬싱키
- Shukla PJ, "Systematic review: should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer?", Saudi J Gastroenterol, 16, pp.161~167 (2010)
- Jiang BG, "Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma", Can J Gastroenterol, 25, pp.603~608 (2011)